Psychedelics and Suicide-Related Outcomes: A Systematic Review
Journal of Clinical Medicine February 20, 2025 Shakila Meshkat, Taha Malik, Jennifer Swainson et al. 3 citations
Background/Objectives: Suicide accounts for 1.4% of global deaths, and the slow-acting nature of traditional treatments for suicide risk underscores the need for alternatives. Psychedelic therapies may rapidly reduce suicide risk. This systematic review evaluates impact of psychedelic therapies on suicide-related outcomes. Methods: A systematic search of MEDLINE, Embase, PsycINFO, and...
DOI: 10.3390/jcm14051416 (opens in new tab)
MDMA
Psilocybin
Suicidal ideation
Odds ratio
+7